Management of Tenosynovial Giant Cell Tumor: A Neoplastic and Inflammatory Disease

Overview

Journal J Am Acad Orthop Surg Glob Res Rev

Specialty Orthopedics

Date 2020 Nov 6

PMID 33156160

Citations 25

Authors

John H Healey

Nicholas M Bernthal

Michiel van de Sande

Affiliations

Soon will be listed here.

Abstract

Background: Patients with diffuse tenosynovial giant cell tumor (TGCT) face a high risk of recurrence, progression, and disability. This systematic review assesses the recent evidence of surgical, adjuvant, and systemic treatments for TGCT.

Methods: We searched PubMed and Ovid with the terms "Giant cell tumor of tendon sheath" OR "pigmented villonodular synovitis" OR "tenosynovial giant cell" AND "treatment" OR "surgery."

Inclusion Criteria: published 2013 to present; prospective or retrospective design; English language; > 20 patients with histopathological confirmed diagnosis of TGCT; and ≥ 1 efficacy and/or safety outcome from surgery, systemic drug therapy, or adjuvant yttrium radiosynoviorthesis.

Results: Of the 434 studies identified, 25 met the inclusion criteria. Of 11 studies in patients with disease in the knee, nine examined surgical treatment approaches, and two evaluated adjuvant yttrium radiosynoviorthesis. Of 11 studies in patients with mixed sites of disease, six assessed surgical treatment approaches, and five evaluated systemic drug therapies. Three studies assessed surgery in patients with TGCT in the hand, hip, and ankle or foot.

Discussion: The high rates of recurrence and risks associated with surgery emphasize the need for novel treatments in patients with symptomatic, advanced TGCT. Systemic therapy may be valuable as part of a multidisciplinary approach.

Citing Articles

A phase 4, multicenter, global clinical study to evaluate discontinuation and rechallenge of pexidartinib in patients with tenosynovial giant cell tumor previously treated with pexidartinib.

Desai J, Wagner A, Carrasco Garcia I, Cesari M, Gordon M, Lin C Cancer. 2024; 131(1):e35634.

PMID: 39533157 PMC: 11694331. DOI: 10.1002/cncr.35634.

Endoscopic En Bloc Resection of Giant Cell Tumor of Tendon Sheath of Anterior Ankle.

Szeto W, Lui T Arthrosc Tech. 2024; 13(10):103086.

PMID: 39479050 PMC: 11519857. DOI: 10.1016/j.eats.2024.103086.

Pexidartinib Upfront in a Case of Tenosynovial Giant Cell Tumor: Proof of Concept for a Treatment Paradigm Shift.

Palmerini E, Peta G, Tuzzato G Oncol Ther. 2024; 12(4):833-841.

PMID: 39155359 PMC: 11573934. DOI: 10.1007/s40487-024-00298-z.

Tenosynovial Giant Cell Tumor in the Gruberi Bursa.

Ferreira F, Baptista D, Castro M Balkan Med J. 2024; 41(6):499-500.

PMID: 39145478 PMC: 11589210. DOI: 10.4274/balkanmedj.galenos.2024.2024-4-120.

TURALIO Risk Evaluation and Mitigation Strategy Program (tREMS): 3-year retrospective hepatic safety assessment.

Dharmani C, Fofah O, Fallon M, Rajper A, Wooddell M, Salas M Future Oncol. 2024; 20(33):2559-2564.

PMID: 39023446 PMC: 11534110. DOI: 10.1080/14796694.2024.2373687.

References

Cassier P, Gelderblom H, Stacchiotti S, Thomas D, Maki R, Kroep J . Efficacy of imatinib mesylate for the treatment of locally advanced and/or metastatic tenosynovial giant cell tumor/pigmented villonodular synovitis. Cancer. 2011; 118(6):1649-55. DOI: 10.1002/cncr.26409. View

Verspoor F, Mastboom M, Hannink G, Maki R, Wagner A, Bompas E . Long-term efficacy of imatinib mesylate in patients with advanced Tenosynovial Giant Cell Tumor. Sci Rep. 2019; 9(1):14551. PMC: 6786996. DOI: 10.1038/s41598-019-51211-y. View

Xie G, Jiang N, Liang C, Zeng J, Chen Z, Xu Q . Pigmented villonodular synovitis: a retrospective multicenter study of 237 cases. PLoS One. 2015; 10(3):e0121451. PMC: 4370558. DOI: 10.1371/journal.pone.0121451. View

Capellen C, Tiling R, Klein A, Baur-Melnyk A, Knosel T, Birkenmaier C . Lowering the recurrence rate in pigmented villonodular synovitis: A series of 120 resections. Rheumatology (Oxford). 2018; 57(8):1448-1452. DOI: 10.1093/rheumatology/key133. View

Patel K, Gikas P, Pollock R, Carrington R, Cannon S, Skinner J . Pigmented villonodular synovitis of the knee: A retrospective analysis of 214 cases at a UK tertiary referral centre. Knee. 2017; 24(4):808-815. DOI: 10.1016/j.knee.2017.03.011. View

Korim M, Clarke D, Allen P, Richards C, Ashford R . Clinical and oncological outcomes after surgical excision of pigmented villonodular synovitis at the foot and ankle. Foot Ankle Surg. 2014; 20(2):130-4. DOI: 10.1016/j.fas.2014.01.007. View

Tap W, Wainberg Z, Anthony S, Ibrahim P, Zhang C, Healey J . Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor. N Engl J Med. 2015; 373(5):428-37. DOI: 10.1056/NEJMoa1411366. View

van der Heijden L, Mastboom M, Dijkstra P, van de Sande M . Functional outcome and quality of life after the surgical treatment for diffuse-type giant-cell tumour around the knee: a retrospective analysis of 30 patients. Bone Joint J. 2014; 96-B(8):1111-8. DOI: 10.1302/0301-620X.96B8.33608. View

Georgiannos D, Boutsiadis A, Agathangelidis F, Papastergiou S, Karataglis D, Bisbinas I . Arthroscopically-assisted mini open partial synovectomy for the treatment of localized pigmented villonodular synovitis of the knee. A retrospective comparative study with long-term follow up. Int Orthop. 2016; 41(5):925-930. DOI: 10.1007/s00264-016-3348-3. View

10.

Mastboom M, Verspoor F, Verschoor A, Uittenbogaard D, Nemeth B, Mastboom W . Higher incidence rates than previously known in tenosynovial giant cell tumors. Acta Orthop. 2017; 88(6):688-694. PMC: 5694816. DOI: 10.1080/17453674.2017.1361126. View

11.

Staals E, Ferrari S, Donati D, Palmerini E . Diffuse-type tenosynovial giant cell tumour: Current treatment concepts and future perspectives. Eur J Cancer. 2016; 63:34-40. DOI: 10.1016/j.ejca.2016.04.022. View

12.

Mastboom M, Palmerini E, Verspoor F, Rueten-Budde A, Stacchiotti S, Staals E . Surgical outcomes of patients with diffuse-type tenosynovial giant-cell tumours: an international, retrospective, cohort study. Lancet Oncol. 2019; 20(6):877-886. DOI: 10.1016/S1470-2045(19)30100-7. View

13.

Colman M, Ye J, Weiss K, Goodman M, McGough 3rd R . Does combined open and arthroscopic synovectomy for diffuse PVNS of the knee improve recurrence rates?. Clin Orthop Relat Res. 2012; 471(3):883-90. PMC: 3563816. DOI: 10.1007/s11999-012-2589-8. View

14.

Koutserimpas C, Kastanis G, Ioannidis A, Filippou D, Balalis K . Giant cell tumors of the tendon sheath of the hand: an 11-year retrospective study. J BUON. 2018; 23(5):1546-1551. View

15.

Cupp J, Miller M, Montgomery K, Nielsen T, OConnell J, Huntsman D . Translocation and expression of CSF1 in pigmented villonodular synovitis, tenosynovial giant cell tumor, rheumatoid arthritis and other reactive synovitides. Am J Surg Pathol. 2007; 31(6):970-6. DOI: 10.1097/PAS.0b013e31802b86f8. View

16.

Mastboom M, Staals E, Verspoor F, Rueten-Budde A, Stacchiotti S, Palmerini E . Surgical Treatment of Localized-Type Tenosynovial Giant Cell Tumors of Large Joints: A Study Based on a Multicenter-Pooled Database of 31 International Sarcoma Centers. J Bone Joint Surg Am. 2019; 101(14):1309-1318. DOI: 10.2106/JBJS.18.01147. View

17.

Gelderblom H, Cropet C, Chevreau C, Boyle R, Tattersall M, Stacchiotti S . Nilotinib in locally advanced pigmented villonodular synovitis: a multicentre, open-label, single-arm, phase 2 trial. Lancet Oncol. 2018; 19(5):639-648. DOI: 10.1016/S1470-2045(18)30143-8. View

18.

Noailles T, Brulefert K, Briand S, Longis P, Andrieu K, Chalopin A . Giant cell tumor of tendon sheath: Open surgery or arthroscopic synovectomy? A systematic review of the literature. Orthop Traumatol Surg Res. 2017; 103(5):809-814. DOI: 10.1016/j.otsr.2017.03.016. View

19.

Mollon B, Lee A, Busse J, Griffin A, Ferguson P, Wunder J . The effect of surgical synovectomy and radiotherapy on the rate of recurrence of pigmented villonodular synovitis of the knee: an individual patient meta-analysis. Bone Joint J. 2015; 97-B(4):550-7. DOI: 10.1302/0301-620X.97B4.34907. View

20.

Keyhani S, Kazemi S, Ahn J, Verdonk R, Soleymanha M . Arthroscopic Treatment of Diffuse Pigmented Villonodular Synovitis of the Knee: Complete Synovectomy and Septum Removal-Midterm Results. J Knee Surg. 2018; 32(5):427-433. DOI: 10.1055/s-0038-1646929. View